187 related articles for article (PubMed ID: 2114360)
41. Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.
Duchêne M; Barron C; Schweizer A; von Specht BU; Domdey H
J Bacteriol; 1989 Aug; 171(8):4130-7. PubMed ID: 2502533
[TBL] [Abstract][Full Text] [Related]
42. Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin.
Toth A; Schödel F; Duchêne M; Massarrat K; Blum B; Schmitt A; Domdey H; von Specht BU
Vaccine; 1994 Oct; 12(13):1215-21. PubMed ID: 7839727
[TBL] [Abstract][Full Text] [Related]
43. Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.
DiGiandomenico A; Rao J; Goldberg JB
Infect Immun; 2004 Dec; 72(12):7012-21. PubMed ID: 15557624
[TBL] [Abstract][Full Text] [Related]
44. Vaccination with a recombinant OprL fragment induces a Th17 response and confers serotype-independent protection against Pseudomonas aeruginosa infection in mice.
Gao C; Yang F; Wang Y; Liao Y; Zhang J; Zeng H; Zou Q; Gu J
Clin Immunol; 2017 Oct; 183():354-363. PubMed ID: 28970186
[TBL] [Abstract][Full Text] [Related]
45. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
Moriyama K; Wiener-Kronish JP; Sawa T
Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
[TBL] [Abstract][Full Text] [Related]
46. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.
Göcke K; Baumann U; Hagemann H; Gabelsberger J; Hahn H; Freihorst J; von Specht BU
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):167-71. PubMed ID: 12832121
[TBL] [Abstract][Full Text] [Related]
47. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
[TBL] [Abstract][Full Text] [Related]
48. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
Saha S; Takeshita F; Sasaki S; Matsuda T; Tanaka T; Tozuka M; Takase K; Matsumoto T; Okuda K; Ishii N; Yamaguchi K; Klinman DM; Xin KQ; Okuda K
Vaccine; 2006 Sep; 24(37-39):6240-9. PubMed ID: 16806598
[TBL] [Abstract][Full Text] [Related]
49. A new polyvalent pseudomonas vaccine.
Merle P; Robbel L; Hungerer KD
Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
[TBL] [Abstract][Full Text] [Related]
50. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
51. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
Moroz AF; Antsiferova NG; Radkevich SA; Mishina VS
Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
[TBL] [Abstract][Full Text] [Related]
52. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
Gartner T; Baeten M; Otieno S; Revets H; De Baetselier P; Huygen K
Immunol Lett; 2007 Jul; 111(1):26-35. PubMed ID: 17570535
[TBL] [Abstract][Full Text] [Related]
53. Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization.
Ahmadbeigi Y; Chirani AS; Soleimani N; Mahdavi M; Goudarzi M
Mol Immunol; 2020 Aug; 124():70-82. PubMed ID: 32540517
[TBL] [Abstract][Full Text] [Related]
54. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
[TBL] [Abstract][Full Text] [Related]
55. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
[TBL] [Abstract][Full Text] [Related]
56. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
[TBL] [Abstract][Full Text] [Related]
57. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
Haberstroh J; Gilleland HE; von Specht BU
Eur Surg Res; 2005; 37(5):265-73. PubMed ID: 16374008
[TBL] [Abstract][Full Text] [Related]
58. A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
Yu X; Wang Y; Xia Y; Zhang L; Yang Q; Lei J
Vaccine; 2016 Aug; 34(37):4399-405. PubMed ID: 27449680
[TBL] [Abstract][Full Text] [Related]
59. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
[TBL] [Abstract][Full Text] [Related]
60. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; van Boven CP
Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
